The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Basaboini Malathi
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Basaboini Malathi, along with three persons acting in concert (family members Mallikarjun Rao Basaboini, Mrinalini Basaboini, and Mriganayani Basaboini), acquired 15,00,000 equity shares of Samsrita Labs Ltd through a preferential allotment on 18 July 2025. The acquirers held zero shares before the allotment and collectively hold 6.56% of the company after the issue. The filing explicitly states the acquirers do not belong to the promoter or promoter group. The company's total share capital expanded from about 1.48 crore shares to about 2.28 crore shares as a result of this preferential allotment, which is why the disclosure under Reg 29(1) was triggered on crossing the 5% substantial shareholder threshold.
A new non-promoter shareholder group has built a 6.56% stake in the company, giving them voting influence at shareholder meetings, while existing shareholders face dilution of over 50% from the preferential issuance.